Laura Tyler Perryman
Director/Miembro de la Junta en Stimwave Technologies, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Aure Bruneau | M | - |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Paul LaViolette | M | 66 |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Jeffrey Goldberg | M | - |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Marc A. Loev | M | - |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Regina Groves | F | 66 |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Richard Chen Mao | M | - |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Gary Perryman | M | - |
Stimwave Technologies, Inc.
Stimwave Technologies, Inc. BiotechnologyHealth Technology Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 7 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Laura Tyler Perryman
- Red Personal